How accurate are patients in reporting their antidepressant treatment history?

Journal of Affective Disorders

Volumn 75, Issue 2, 2003, Pages 115-124

  Posternak, Michael A ^a,b   Zimmerman, Mark ^a  

^a BROWN UNIVERSITY   (United States)

^b Bayside Medical Center   (United States)

Author keywords

Antidepressant therapy; Augmentation; Major depression; Recall; Treatment

Indexed keywords

ANTIDEPRESSANT AGENT;

ADULT; ANAMNESIS; ARTICLE; CLINICAL TRIAL; DEPRESSION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL PRACTICE; MEDICAL RECORD; MEDICAL SPECIALIST; MENTAL HEALTH CENTER; MONOTHERAPY; OUTPATIENT DEPARTMENT; PATIENT INFORMATION; PRIORITY JOURNAL; PSYCHOLOGIC TEST; TREATMENT OUTCOME;

EID: 0038730792     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0327(02)00049-6     Document Type: Article

References (15)

1. Fava M., Davidson K.G. Definition and epidemiology of treatment-resistant depression. Psychiatr. Clin. North Am. 19:1996;179-200.
2. Festinger L. A Theory of Cognitive Dissonance. 1957;Stanford University Press, Stanford, CA.
3. First M.B., Spitzer R.L., Williams J.B.W., Gibbon M. Structured Clinical Interview for DSM-IV (SCID). 1997;American Psychiatric Association, Washington, DC.
4. Guy, W., 1976. ECDEU Assessment Manual for Psychopharmacology. US Department of Health, Education, and Welfare publication (ADM) 76-338, Vol. 23. National Institute of Mental Health, Rockville, MD, pp. 56-62.
5. Janicak P.G., Davis J.M., Preskorn S.H., Ayd F.J. Principles and Practice of Psychopharmacotherapy. 2nd Edition:1997;Williams and Wilkins, Baltimore, MD.
6. Nierenberg A.A., Keck P.E., Samson J., Rothschild A.J., Schatzberg A.F. Methodological considerations for the study of treatment-resistant depression. Amsterdam J.D. Advances in Neuropsychiatry and Psychopharmacology. Vol. 2:1991;pp. 1-12 Raven Press, New York.
7. Posternak M.A., Zimmerman M. Short-term spontaneous improvement rates in depressed outpatients. J. Nerv. Ment. Disord. 62:2001;799-804.
8. Posternak M.A., Zimmerman M. Switching versus augmentation: a prospective, naturalistic comparison in depressed, treatment-resistant patients. J. Clin. Psychiatry. 62:2001;135-142.
9. Posternak, M.A., Zimmerman, M., Keitner, G.I., Miller, I.W. A reevaluation of the exclusion criteria used in antidepressant efficacy trials. Am. J. Psychiatry 159, 191-200.
10. Prudic J., Haskett R.F., Mulsant B., Malone K.M., Pettinati J.M., Stephens S., Greenberg R., Rifas S.L., Sackeim H.A. Resistance to antidepressant medications and short-term clinical response to ECT. Am. J. Psychiatry. 153:1996;985-992.
11. Remillard A.J., Blackshaw S.L., Dangor A.S.O. Differential responses to a single antidepressant in recurrent episodes of major depression. Hosp. Community Psychiatry. 45:(4):1994;359-361.
12. Sackeim H.A., Prudic J., Devanand D.P., Decina P., Kerr B., Malitz S. The impact of medication resistance and continuation pharmacotherapy on relapse following response to electroconvulsive therapy in major depression. J. Clin. Psychopharmacol. 10:1990;96-104.
13. Zimmerman M., Mattia J.I. Psychiatric diagnosis in clinical practice: Is comorbidity being missed? Compr. Psychiatry. 40:1999;182-191.
14. Zimmerman, M., Mattia, J.I., 2000a. A new self-report outcomes scale: the Multidimensional Assessment of Symptoms and Psychological Functioning (MASP). Paper presented at the 34th Annual Association for the Advancement of Behavior Therapy Meeting, New Orleans, LA.
15. Zimmerman M., Mattia J.I. Principal and additional DSM-IV disorders for which outpatients seek treatment. Psychiatr. Serv. 51:2000;1299-1304.